C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2002
11/27/2002	CN1381564A Polypeptide-human phosphate synthetase-11.55 and polynucleotide for coding it
11/27/2002	CN1094975C Bacillus proteases
11/27/2002	CA2414037A1 Dna sequence regulating plant fruit-specific expression
11/26/2002	US6486383 Modification of starch content in plants
11/26/2002	US6486380 Pancreatic β cell hexokinase transgene
11/26/2002	US6486331 Substituted alkylketo compounds and process
11/26/2002	US6486314 Glucan incorporating 4-, 6-, and 4, 6- linked anhydroglucose units
11/26/2002	US6486306 Filtration
11/26/2002	US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
11/26/2002	US6486302 Hm2 cDNA and related polypeptide
11/26/2002	US6486300 Human nm23-like protein
11/26/2002	US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002	US6486181 Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
11/26/2002	US6486131 As diagnostic and therapeutic assays and reagents for detecting and therapy of proliferative disorders arising from, for example, tumorigenic transformation of cells, or other hyperplastic or neoplastic transformation processes
11/26/2002	US6486113 Mutant α-amylases
11/26/2002	US6485957 DNA encoding the human serine protease EOS
11/26/2002	US6485956 Testis-specific human SVPH1-8 proteinase
11/26/2002	US6485955 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
11/26/2002	US6485954 Enzyme with galactanase activity
11/26/2002	US6485953 Enzyme capable of hydorlyzing plaque, microorganism producing the same, and a composition comprising the same
11/26/2002	US6485951 Derived from pseudomonas jessenii
11/26/2002	US6485950 Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
11/26/2002	US6485949 Epoxidation of carbon-carbon double bond with membrane bound peroxygenase
11/26/2002	US6485948 Carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme
11/26/2002	US6485937 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
11/26/2002	US6485935 Structure of the ankyrin binding domain of a α-Na, K-ATPase
11/26/2002	US6485934 Regulatory system for inducible expression of genes with lambdoid promoters
11/26/2002	US6485931 Converting cholesterol contained in foods and feeds to coprostanol having very low absorbability by utilizing dehydrogenase enzymes
11/26/2002	US6485930 Mannosyl transfer with regeneration of GDP-mannose
11/26/2002	US6485921 UBCLP and uses thereof
11/26/2002	US6485914 Method of detecting chlamydia pneumoniae gene using polynucleotides
11/26/2002	US6485909 DNA polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides
11/26/2002	US6485904 DNA encoding a plasminogen activating protein
11/26/2002	US6485761 Incorporating into the dough one or more lactonohydrolases, to improve properties such as: strength, stability, stickiness, or machinability of the dough; volume, crumb structure, softness, flavor, and antistaling of the baked product
11/26/2002	US6485722 Method for selective engraftment of drug-resistant hematopoietic stem cells
11/26/2002	CA2210247C Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
11/26/2002	CA2105984C Cloning and expression of renilla luciferase
11/26/2002	CA2073734C Humane thrombine concentrate preparation process for therapeutic use
11/26/2002	CA2026703C Genetic manipulations with recombinant dna comprising sequences derived from rna virus
11/22/2002	WO2001090335A1 Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme
11/22/2002	CA2409961A1 New cyclodextrin glucanotransferase, method of manufacturing same, and method of manufacturing cyclodextrin employing this enzyme
11/21/2002	WO2002093177A2 Assays for identifying modulators of rhomboid polypeptides
11/21/2002	WO2002093173A2 Screening method using pim1-kinase or pim3-kinase
11/21/2002	WO2002093132A2 Method for manufacture of fine particles
11/21/2002	WO2002092844A1 Thermostable proteinases from thermophilic bacteria
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092840A2 Agents that regulate apoptosis
11/21/2002	WO2002092822A2 Leaf specific gene promoter of coffee
11/21/2002	WO2002092820A1 Lentil plants having increased resistance to imidazolinone herbicides
11/21/2002	WO2002092811A1 Method of expressing long-chain prenyl diphosphate synthase
11/21/2002	WO2002092809A1 Novel hexenuronidase, gene coding for the same, and use of these
11/21/2002	WO2002092805A1 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tuberculosis
11/21/2002	WO2002092804A1 Metalloprotease m8 polynucleotides and polypeptides and screening methods
11/21/2002	WO2002092803A1 Phosphotriesterase from agrobacterium radiobacter p230
11/21/2002	WO2002092802A1 Novel methods of enzyme purification
11/21/2002	WO2002092801A2 Methods and compositions for making emamectin
11/21/2002	WO2002092800A2 Crystal structure of 2c-methyl-d-erythritol 2,4-cyclodiphosphate synthase
11/21/2002	WO2002092799A2 Regulation of human steroid 5-alpha reductase-like protein
11/21/2002	WO2002092798A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/21/2002	WO2002092797A2 Alpha-amylase variant with altered properties
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092777A2 Dwf12 and mutants thereof
11/21/2002	WO2002092775A2 Tumor antigen homologous to poly(a) polymerase
11/21/2002	WO2002092768A2 Novel alanine transaminase enzyme and methods of use
11/21/2002	WO2002092760A2 SERINE THREONINE KINASE MEMBER, h2520-40
11/21/2002	WO2002092741A2 0etergent compositions comprising bacillus subtilis pectate lyases
11/21/2002	WO2002092623A1 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
11/21/2002	WO2002092622A2 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors
11/21/2002	WO2002092563A2 Protease inhibitors
11/21/2002	WO2002092134A1 Lentiviral vectors encoding clotting factors for gene therapy
11/21/2002	WO2002092128A1 Compositions and methods to regulate serum phosphate
11/21/2002	WO2002092024A2 Compounds and methods for inhibiting axillary malodour
11/21/2002	WO2002092020A2 Compositions and methods for modulating bone mineral deposition
11/21/2002	WO2002091991A2 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002074907A3 Methods of modulating surfactant production
11/21/2002	WO2002068933A3 Small molecule design against drug resistant mutants using directed evolution
11/21/2002	WO2002064750A3 Expression system for seed proteins
11/21/2002	WO2002064624A3 Improved method for production of secreted proteins in fungi
11/21/2002	WO2002055712A3 Regulation of human alanine aminotransferase
11/21/2002	WO2002046381A3 Method for the prevention or reduction of haze in beverages
11/21/2002	WO2002044351A3 Regulation of human fatty acid coa ligase
11/21/2002	WO2002042468A3 Glycosyltransferase vectors for treating cancer
11/21/2002	WO2002042418A9 3-hydroxypropionic acid and other organic compounds
11/21/2002	WO2002040536A3 Acylated antimicrobial peptides
11/21/2002	WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
11/21/2002	WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002	WO2002008392A3 Regulation of human matriptase-like serine protease
11/21/2002	WO2001094383A3 Mutated furin polypeptides having improved characteristics
11/21/2002	WO2001080876A8 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator
11/21/2002	US20020174452 Modifying lignan content in plants by transforming plants with vectors containing a DNA sequence encoding one or more proteins integral to the phenylpropanoid pathway leading to G-lignan formation
11/21/2002	US20020174450 Transgenic mice containing cash gene disruptions
11/21/2002	US20020173641 Nucleotide sequences coding polypeptides for use in human therapeutics, pharmacology and diagnostics
11/21/2002	US20020173640 Nucleotide sequences coding plypeptide for use in the treatment of tumors
11/21/2002	US20020173639 Novel human asparaginases and polynucleotides encoding the same
11/21/2002	US20020173637 Nucleotide sequences coding polypeptide for use in the generation of lysine for use in medicines
11/21/2002	US20020173633 Characterization of phenylalanine ammonia-lyase (PAL) gene in wounded lettuce tissue
11/21/2002	US20020173630 33217, a novel human AMP-binding enzyme family member and uses thereof
11/21/2002	US20020173530 Single morphic forms of metalloproteinase inhibitors
11/21/2002	US20020173481 Regulation of vascular endothelium using BMX tyrosine kinase

1 ... 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 ... 1416